Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Hepatol. 2020 Nov 24;74(4):850–859. doi: 10.1016/j.jhep.2020.11.023

Table 4.

Comparison of cases and controls with respect to occurrence of screening (defined as definitely or probably screening) prior to the index date.

Controls N=169 Cases N=169 Unadjusted OR (95% CI) Adjusteda OR (95% CI)
0–4 years prior to the index date
No screening 70 (41.4%) 112 (66.3%) 1 1
Either USS or AFP 99 (58.6%) 57 (33.7%) 0.19 (0.10–0.38) 0.21 (0.09–0.50)
AFP only 34 (20.1%) 21 (12.4%) 0.33 (0.12–0.92) 0.22 (0.05–1.00)
USS onlyb 7 (4.1%) 3 (1.8%) -- --
Both USS and AFP 58 (34.3%) 33 (19.5%) 0.12 (0.04–0.34) 0.11 (0.03–0.40)
0–3 years prior to index date
No screening 76 (45.0%) 117 (69.2%) 1 1
Either USS or AFP 93 (55.0%) 52 (30.8%) 0.24 (0.13–0.44) 0.24 (0.11–0.52)
AFP only 32 (18.9%) 21 (12.4%) 0.40 (0.16–1.03) 0.37 (0.10–1.38)
USS onlyb 6 (3.6%) 4 (2.4%) -- --
Both USS and AFP 55 (32.5%) 27 (16.0%) 0.17 (0.07–0.41) 0.12 (0.04–0.38)
0–2 years prior to index date
No screening 86 (50.9%) 123 (72.8%) 1 1
Either USS or AFP 83 (49.1%) 46 (27.2%) 0.26 (0.14–0.48) 0.26 (0.13–0.55)
AFP only 32 (18.9%) 19 (11.2%) 0.29 (0.11–0.80) 0.31 (0.09–1.08)
USS onlyb 8 (4.7%) 4 (2.4%) -- --
Both USS and AFP 43 (25.4%) 23 (13.6%) 0.24 (0.11–0.55) 0.15 (0.05–0.42)
0–1 year prior to index date
No screening 103 (60.9%) 129 (76.3%) 1 1
Either USS or AFP 66 (39.1%) 40 (23.7%) 0.41 (0.24–0.71) 0.42 (0.22–0.81)
AFP only 33 (19.5%) 18 (10.7%) 0.45 (0.20–0.99) 0.54 (0.21–1.35)
USS onlyb 10 (5.9%) 7 (4.1%) -- --
Both USS and AFP 23 (13.6%) 15 (8.9%) 0.31 (0.11–0.85) 0.22 (0.06–0.73)
a

Adjusted for age, race/ethnicity, BMI, diabetes, alcohol use disorder, HIV coinfection, HBV e Ag positive, HBV DNA maximum viral load, years from HBV diagnosis to index date, and receipt of CT or MRI in the window.

b

Unable to calculate odds ratio because too few patients received USS only.

Abbreviations: OR – odds ratio, CI – confidence interval, USS – ultrasound, AFP – alpha fetoprotein